Stay updated on Cabozantinib for Young Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.

Latest updates to the Cabozantinib for Young Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedAdded medullary thyroid carcinoma to the conditions list and included Genetic and Rare Diseases Information Center as a resources link.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now displays revision v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check27 days agoChange DetectedSite updated from version 3.4.2 to 3.4.3; no changes to study content or user-facing functionality are evident.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-status notice about government funding and the previous Revision: v3.4.1. These are administrative changes and do not affect the study information on the page.SummaryDifference0.3%

- Check62 days agoChange DetectedThe page now includes a government funding lapse notice indicating the NIH Clinical Center is open and operations may be affected, and the site version has been updated to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check69 days agoChange DetectedAdded: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deleted: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib for Young Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.